![Mark Joseph Cantwell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Joseph Cantwell
Technik-/Wissenschafts-/F&E-Leiter bei Memgen, Inc.
Profil
Mark Joseph Cantwell is currently the Chief Scientific Officer & Director at Memgen, Inc. Previously, he worked as the Vice President-Research & Development at Mast Therapeutics, Inc. He completed his undergraduate degree at Georgia Institute of Technology and his doctorate at the University of California San Diego.
Aktive Positionen von Mark Joseph Cantwell
Unternehmen | Position | Beginn |
---|---|---|
Memgen, Inc.
![]() Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Mark Joseph Cantwell
Unternehmen | Position | Ende |
---|---|---|
Mast Therapeutics, Inc.
![]() Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Mark Joseph Cantwell
Georgia Institute of Technology | Undergraduate Degree |
University of California San Diego | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Mast Therapeutics, Inc.
![]() Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Memgen, Inc.
![]() Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Health Technology |